# EXBLIFEP
> **NDA216165** · New Drug Application · Sponsor: ORCHID PHARMA · Approved 2024-02-22
## Drug
- **FDA Application Number:** NDA216165
- **Application type:** New Drug Application
- **Brand name:** EXBLIFEP
- **Generic name:** Cefepime Hydrochloride
- **Active ingredients:** CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** ORCHID PHARMA
- **First approval:** 2024-02-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216165)
---
*AI Analytics · CC0 1.0*